ロード中...

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

Resveratrol (RSV) is a potential alternative therapy for non-alcoholic fatty liver disease (NAFLD) that has been evaluated in many clinical trials, but the mechanisms of RSV action have not been fully elucidated. Recent studies suggested that the gut microbiota is an important RSV target; therefore,...

詳細記述

保存先:
書誌詳細
出版年:Front Microbiol
主要な著者: Du, Fan, Huang, Rongfeng, Lin, Dan, Wang, Yuying, Yang, Xiaohuang, Huang, Xiaoyun, Zheng, Biyun, Chen, Zhixin, Huang, Yuehong, Wang, Xiaozhong, Chen, Fenglin
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2021
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7942199/
https://ncbi.nlm.nih.gov/pubmed/33708180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2021.611323
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!